| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.042 | 0.8 |